Prevalence of metalo- β-lactamase-producing (MBL) Acinetobacter species in a tertiary care hospital
,
Abstract
Background and Objectives: Acinetobacter causes a wide variety of illness in debilitated and hospitalized patients. Carbapenem resistance in Acinetobacter is an emerging problem and is a cause of concern as many nosocomial infections with Acinetobacter are resistant to most other antibiotics. The present study was aimed to study metallo-β-lactamase (MBL) production in Acinetobacter species.
Material and Methods: During one year prospective study, all isolates of Acinetobacter obtained from various clinical samples like respiratory, pus, blood and others were included. Antimicrobial susceptibility testing was done by standard Kirby Bauer disk diffusion method. Metallo β-lactamase (MBL) detection was done by imipenem-EDTA combined disk method.
Results: Among 1017 isolates, 964 were A. baumannii, 48 were A. lwoffii and 5 were A. hemolyticus. Out of these, majority of the isolates were obtained from respiratory samples, followed by pus. A. baumannii showed high level of resistance to cephalosporins, cotrimoxazole and piperacillin. A. lwoffii and A. hemolyticus showed lesser resistance to all antibiotics. Imipenem resistance was observed in 389 (40.3 %) isolates of A. baumannii and MBL activity was seen in 80.3% of isolates. MBL positive isolates of A. baumannii showed higher resistance as compared to MBL negative isolates.
Conclusion: This study demonstrated that multidrug resistant strains of Acinetobacter are common in tertiary care hospitals. Unwarranted and unrestricted usage of antibiotics is associated with emergence of resistance in nosocomial pathogens. Regular monitoring and documentation of carbapenem resistant is crucial in developing strategies to control infection due to these bacteria.
Bergogne–Berezin E, Towner KJ. Acinetobacter species as nosocomial pathogens: Microbiological, clinical and epidemiological features. Clin Micro Rev 1996; 9:148-165.
Manikal VM, Landman D, Saurina G, Oydna E, Lal H, Quale J. Endemic carbapenem resistant Acinetobacter species in Brooklyn, New York: citywide prevalence, inter institutional spread and relation to antibiotic usage. Clin Infect Dis 2000; 31: 101-106.
Maltezou HC, “Metallo-β-lactamases in Gram-negative bacteria: introducing the era of pan-resistance?” International Journal of Antimicrobial Agents 2009; 33:405 e1-405 e7.
Peymani A, Nahaei MR, Farajnia S, Hasani A, Mirsalehian A, Sohrabi N, et al. High prevalence of metallo-beta-lactamase-producing Acinetobacter baumannii in a teaching hospital in Tabriz, Iran. Jpn J Infect Dis 2011; 64: 69-71.
Gupta V, Datta P and Chander J. Prevalence of metallo-β lactamase (MBL) producing Pseudomonas spp. and Acinetobacter spp. in a tertiary care hospital in India. J Infect 2006; 52: 311-314.
Yong D, Lee K, Yum JH, Shin HB, Rossolini GM and Chong Y. Imipenem-EDTA disk method for differentiation of metallo-β-lactamase-producing clini- cal isolates of Pseudomonas spp. and Acinetobacter spp. J Clin Microbiol 2002; 40: 3798-3801.
Quale J, Bratu S, Landman D, Heddurshetti R. Molecular epidemiology and mechanisms of carbapenem resistance in Acinetobacter baumannii endemic in New York City. Clin Infect Dis 2003; 37: 214-220.
Urban C, Segal-Maurer S, Rahal JJ. Consideration in control and treatment of nosocomial infections due to multidrug resistant Acinetobacter baumannii. Clin Infect Dis 2003; 36: 1268-1274.
Winn W Jr, Allen S, Janda W, Koneman E, Procop G, Schreckenberger P, et al., editors. Nonfermenting Gram negative bacilli. In: Koneman’s Color Atlas and textbook of Diagnostic Microbiology, 6 th ed. USA: Lippincott Williams and Wilkins Company; 2006. pp.305-391.
Performance standards for antimicrobial susceptibility testing; seventeenth informational supplement CLSI document, Jan 2007. M-100-S17 vol. 27 No: 1.
Kumar V, Neelagund YF. Acinetobacter septicemia in neonates. Ind J Med Microbiol 2004; 22: 71.
Shete VB, Ghadage DP, Muley VA, Bhore AV.
Acinetobacter septicemia in neonates admitted to intensive care units. J Lab Physicians 2009; 1: 73-76.
Malini A, Deepa EK, Gokul BN, Prasad SR.Nonfermenting gram-negative bacilli infections in a tertiary care hospital in Kolar, Karnataka. Journal of laboratory physicians 2009; 1: 62-66.
Meharwal SK, Taneja N, Sharma SK, Sharma M.Complicated nosocomial UTI caused by nonfermenters. Indian J Urol 2002; 18: 123-128.
Maria CB, Andrade SS, Silbert S, Gales AC, Jones RN, Sader HS. Resistance trends of Acinetobacter spp. in Latin America and characterization of international dissemination of multi-drug resistant strains: five-year report of the SENTRY Antimicrobial Surveillance Program. Int J Infect Dis 2004; 8: 284-291.
Gladstone P, Rajendran P, Brahmadathan KN. Incidence of carbapenem resistant nonfermenting gram negative bacilli from patients with respiratory infections in the intensive care units. Indian J Med Microbiol 2005; 23:189-191.
Hodiwala (Bhesania) A, Dhoke R, Urhekar AD. Incidence of metallo-beta-lactamase producing pseudo- monas, Acinetobacter & enterobacterial isolates in hospitalised patients. Int J PharmBioSci 2013; 3: 79-83.
Kabbaj H, Seffar M, Belefquih B, Akka D, Handor N, Amor M et al. Prevalence of Metallo-β- Lactamases Producing Acinetobacter baumannii in a moroccan Hospital. ISRN Infectious Diseases 2013; Article ID 154921, 3 pages www.hindawi.com/isrn/ id/2013/154921.
John S, Balagurunathan R. Metallo beta lactamase producing Pseudomonas aeruginosa and Acinetobacter baumannii. Indian J Med Microbiol 2011; 29: 302-304.
Irfan S, Zafar A, Guhar D, Ahsan T, Hasan R. Metallo- β-lactamase producing clinical isolates of Acinetobacter species and Pseudomonas aeruginosa from intensive care unit patients of a tertiary care hospital. Indian J Med Microbiol 2008; 26: 243-245 .
Pitout JD, Gregson DB, Poirel L, McClure JA, Le P, Church DL. Detection of Pseudomonas aeruginosa producing metallo-β-lactamases in a large centralized laboratory. J Clin Microbiol 2005; 43: 3129-3135.
Varaiya A, Kulkarni N, Kulkarni M, Bhalekar P, Dogra J. Incidence of metallo-β-lactamase producing Pseudomonas aeruginosa in ICU patients. Indian J Med Res 2008; 127: 398-402.
Livermore DM, Woodford N. Carbapenemse: A problem in waiting? Curr Opin Microbiol 2000; 3: 489-495.
| Files | ||
| Issue | Vol 6 No 1 (2014) | |
| Section | Articles | |
| Keywords | ||
| A.baumannii Carbapenem resistance metallo ß-lactamase | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
